CASC2 and central nervous system cancer: CASC2 was down-regulated in glioma, and overexpression of CASC2 reduced TMZ-induced autophagy via mTOR up-regulation by targetting miR-193a-5p, thus enhancing the sensitivity of glioma cells to TMZ cytotoxicity [88].